82
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Key Molecular Mechanisms of Sini Decoction Plus Ginseng Soup to Rescue Acute Liver Failure: Regulating PPARα to Reduce Hepatocyte Necroptosis?

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 4763-4784 | Published online: 22 Aug 2022

References

  • O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342(8866):273–275. doi:10.1016/0140-6736(93)91818-7
  • Lee WM. Acute liver failure. Semin Respir Crit Care Med. 2012;33(1):36–45. doi:10.1055/s-0032-1301733
  • Bernal W, Wong T, Wendon J. High-volume continuous veno-venous haemofiltration in hyper-acute liver failure: a pilot study. Critical Care. 1999;3(Suppl 1):P212. doi:10.1186/cc585
  • Vaquero J, Polson J, Chung C, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125(3):755–764. doi:10.1016/S0016-5085(03)01051-5
  • Seo M-J, Hong J-M, Kim S-J, Lee S-M. Genipin protects d-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the necroptosis-mediated inflammasome signaling. Eur J Pharmacol. 2017;812:128–137. doi:10.1016/j.ejphar.2017.07.024
  • Dong V, Nanchal R, Karvellas CJ. Pathophysiology of acute liver failure. Nutr Clin Pract. 2020;35(1):24–29. doi:10.1002/ncp.10459
  • Liang TJ, Hepatitis B. the virus and disease. Hepatology. 2009;49(5 Suppl):S13–21. doi:10.1002/hep.22881
  • Sarhan M, Land WG, Tonnus W, Hugo CP, Linkermann A. Origin and consequences of necroinflammation. Physiol Rev. 2018;98(2):727–780. doi:10.1152/physrev.00041.2016
  • Antoine DJ, Dear JW, Lewis PS, et al. Mechanistic biomarkers provide early and sensitive detection of Acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology. 2013;58(2):777–787. doi:10.1002/hep.26294
  • Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192(4):565–570. doi:10.1084/jem.192.4.565
  • Chinetti-Gbaguidi G, Fruchart J-C, Staels B. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy. Curr Opin Pharmacol. 2005;5(2):177–183. doi:10.1016/j.coph.2004.11.004
  • Varga T, Czimmerer Z, Nagy L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta. 2011;1812(8):1007–1022. doi:10.1016/j.bbadis.2011.02.014
  • Standage SW, Caldwell CC, Zingarelli B, Wong HR. Reduced peroxisome proliferator-activated receptor α expression is associated with decreased survival and increased tissue bacterial load in sepsis. Shock. 2012;37(2):164–169. doi:10.1097/SHK.0b013e31823f1a00
  • Jiao M, Ren F, Zhou L, et al. Peroxisome proliferator-activated receptor α activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway. Cell Death Dis. 2014;5(8):e1397. doi:10.1038/cddis.2014.361
  • El-Gibaly AM, Scheuer C, Menger MD, Vollmar B. Improvement of rat liver graft quality by pifithrin-alpha-mediated inhibition of hepatocyte necrapoptosis. Hepatology. 2004;39(6):1553–1562. doi:10.1002/hep.20243
  • Schneeweiss B, Pammer J, Ratheiser K, et al. Energy metabolism in acute hepatic failure. Gastroenterology. 1993;105(5):1515–1521. doi:10.1016/0016-5085(93)90159-A
  • Xue R, Zhu X, Jia L, et al. Mitofusin2, a rising star in acute‐on‐chronic liver failure, triggers macroautophagy via the mTOR signalling pathway. J Cell Mol Med. 2019;23(11):7810–7818. doi:10.1111/jcmm.14658
  • Moreau R, Clària J, Aguilar F, et al. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. J Hepatol. 2020;72(4):688–701. doi:10.1016/j.jhep.2019.11.009
  • Peng S, Xu J, Ruan W, Li S, Xiao F. PPAR-γ activation prevents septic cardiac dysfunction via inhibition of apoptosis and necroptosis. Oxid Med Cell Longev. 2017;2017:8326749. doi:10.1155/2017/8326749
  • Xie F, Wu -Y-Y, Duan G-J, et al. Anti-myocardial ischemia reperfusion injury mechanism of dried ginger-aconite decoction based on network pharmacology. Front Pharmacol. 2021;12:609702. doi:10.3389/fphar.2021.609702
  • Luo J, Zhang Y, Hu X, et al. The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by D-galactosamine in rats. J Ethnopharmacol. 2015;161:53–59. doi:10.1016/j.jep.2014.12.003
  • Luo J-X, Zhang Y, Hu X-Y, et al. Aqueous extract from aconitum carmichaelii debeaux reduces liver injury in rats via regulation of HMGB1/TLR4/NF-ΚB/caspase-3 and PCNA signaling pathways. J Ethnopharmacol. 2016;183:187–192. doi:10.1016/j.jep.2016.01.020
  • Zhang T, Wang G, Bai S, Bai J, Tian L, Hu W. Experimental study on the effect of aconite on the antioxidant system of aged rats. Chin J Gerontol. 2001;2002(02):135–136.
  • Luo H, Huang W, Yang C, et al. Therapeutic efficacy and mechanism of action of ginsenosideRg1 in treating acute hepatic failure in mice. J Chin J Hepatol. 2017;25(03):217–222.
  • Tong X, Mu L, Ji H, Zhen Z, Chang B, Dong L. Textual research on dosage of Treatise on Exogenous Febrile Disease. J Tradit Chin Med. 2009;50(04):368–372.
  • Lin X, Shao T, Huang L, et al. Simiao decoction alleviates gouty arthritis by modulating proinflammatory cytokines and the gut ecosystem. Front Pharmacol. 2020;11:955. doi:10.3389/fphar.2020.00955
  • Du L, Ma Y, Liu M, Yan L, Tang H. Peroxisome Proliferators Activated Receptor (PPAR) agonists activate hepatitis B virus replication in vivo. Virol J. 2017;14(1):96. doi:10.1186/s12985-017-0765-x
  • Yamaura K, Shimada M, Nakayama N, Ueno K. Protective effects of goldenseal (Hydrastis canadensis L.) on Acetaminophen-induced hepatotoxicity through inhibition of CYP2E1 in rats. Pharmacognosy Res. 2011;3(4):250–255. doi:10.4103/0974-8490.89745
  • Rahmatollahi M, Baram SM, Rahimian R, Saeedi Saravi SS, Dehpour AR. Peroxisome proliferator-activated receptor-α inhibition protects against doxorubicin-induced cardiotoxicity in mice. Cardiovasc Toxicol. 2016;16(3):244–250. doi:10.1007/s12012-015-9332-0
  • Kong L, Ren W, Li W, et al. Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice. Lipids Health Dis. 2011;10(1):246. doi:10.1186/1476-511X-10-246
  • Yang R, Wang P, Chen Z, et al. WY-14643, a selective agonist of peroxisome proliferator-activated receptor-α, ameliorates lipopolysaccharide-induced depressive-like behaviors by preventing neuroinflammation and oxido-nitrosative stress in mice. Pharmacol Biochem Behav. 2017;153:97–104. doi:10.1016/j.pbb.2016.12.010
  • Wu C-T, Deng J-S, Huang W-C, Shieh P-C, Chung M-I, Huang G-J. Salvianolic acid C against acetaminophen-induced acute liver injury by attenuating inflammation, oxidative stress, and apoptosis through inhibition of the Keap1/Nrf2/HO-1 signaling. Oxid Med Cell Longev. 2019;2019:9056845. doi:10.1155/2019/9056845
  • Giorgi VSI, Peracoli MTS, Peracoli JC, Witkin SS, Bannwart-Castro CF. Silibinin modulates the NF-κb pathway and pro-inflammatory cytokine production by mononuclear cells from preeclamptic women. J Reprod Immunol. 2012;95(1–2):67–72. doi:10.1016/j.jri.2012.06.004
  • Hong W, Hwang-Bo J, Jeon H, et al. A comparative study of the hepatoprotective effect of centella asiatica extract (CA-HE50) on lipopolysaccharide/d-galactosamine-induced acute liver injury in C57BL/6 mice. Nutrients. 2021;13(11):4090. doi:10.3390/nu13114090
  • Karvellas CJ, Tillman H, Leung AA, et al. Acute liver injury and acute liver failure from mushroom poisoning in North America. Liver Int. 2016;36(7):1043–1050. doi:10.1111/liv.13080
  • Hashem RM, Hassanin KM, Rashed LA, Mahmoud MO, Hassan MG. Effect of silibinin and vitamin E on the ASK1-p38 MAPK pathway in D-galactosamine/lipopolysaccharide induced hepatotoxicity. Exp Biol Med. 2016;241(11):1250–1257. doi:10.1177/1535370216636719
  • Chen X, Li W, Ren J, et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 2014;24(1):105–121. doi:10.1038/cr.2013.171
  • Yamada S, Maruyama I. HMGB1, a novel inflammatory cytokine. Clin Chim Acta. 2007;375(1–2):36–42. doi:10.1016/j.cca.2006.07.019
  • Schetter AJ, Heegaard NHH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31(1):37–49. doi:10.1093/carcin/bgp272
  • Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282(5396):2085–2088. doi:10.1126/science.282.5396.2085
  • Broz P, Cossart P, Roy CR, Sansonetti P. Recognition of intracellular bacteria by inflammasomes. Microbiol Spectr. 2019;7(2):2. doi:10.1128/microbiolspec.BAI-0003-2019
  • Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42(4):245–254. doi:10.1016/j.tibs.2016.10.004
  • Ip E, Farrell G, Hall P, Robertson G, Leclercq I. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology. 2004;39(5):1286–1296. doi:10.1002/hep.20170
  • Patterson AD, Shah YM, Matsubara T, Krausz KW, Gonzalez FJ. Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against Acetaminophen-induced liver toxicity. Hepatology. 2012;56(1):281–290. doi:10.1002/hep.25645
  • Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest. 1999;103(11):1489–1498. doi:10.1172/JCI6223
  • Ashibe B, Motojima K. Fatty aldehyde dehydrogenase is up-regulated by polyunsaturated fatty acid via peroxisome proliferator-activated receptor alpha and suppresses polyunsaturated fatty acid-induced endoplasmic reticulum stress. FEBS J. 2009;276(23):6956–6970. doi:10.1111/j.1742-4658.2009.07404.x
  • Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res. 1996;37(5):907–925. doi:10.1016/S0022-2275(20)42003-6
  • Schlaepfer IR, Joshi M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology. 2020;161(2):bqz046. doi:10.1210/endocr/bqz046
  • Fakurazi S, Hairuszah I, Nanthini U. Moringa oleifera Lam prevents Acetaminophen induced liver injury through restoration of glutathione level. Food Chem Toxicol. 2008;46(8):2611–2615. doi:10.1016/j.fct.2008.04.018
  • Sharma D, Trivedi SS, Bhattacharjee J. Oxidative stress and eNOS (Glu298Asp) gene polymorphism in preeclampsia in Indian population. Mol Cell Biochem. 2011;353(1–2):189–193. doi:10.1007/s11010-011-0786-5
  • Wang X, Ning Q. Immune mediated liver failure. EXCLI J. 2014;13:1131–1144.
  • Cho Y, Challa S, Moquin D, et al. Phosphorylation-driven assembly of RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 2009;137(6):1112–1123. doi:10.1016/j.cell.2009.05.037
  • Wallach D, Kang T-B. Programmed cell death in immune defense: knowledge and presumptions. Immunity. 2018;49(1):19–32. doi:10.1016/j.immuni.2018.06.019
  • Wang H-L, Tsao S-M, Yeh C-B, Chou Y-E, Yang S-F. Circulating level of high mobility group box-1 predicts the severity of community-acquired pneumonia: regulation of inflammatory responses via the c-Jun N-terminal signaling pathway in macrophages. Mol Med Rep. 2017;16(3):2361–2366. doi:10.3892/mmr.2017.6892
  • Wang Y, Zhang H, Chen Q, et al. TNF-α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury. Cell Prolif. 2020;53(6):e12829. doi:10.1111/cpr.12829
  • Mohammed S, Nicklas EH, Thadathil N, et al. Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress. Free Radic Biol Med. 2021;164:315–328. doi:10.1016/j.freeradbiomed.2020.12.449
  • Lu Y-N, Zhao X-D, Xu X, et al. Arctigenin exhibits hepatoprotective activity in Toxoplasma gondii-infected host through HMGB1/TLR4/NF-κB pathway. Int Immunopharmacol. 2020;84:106539. doi:10.1016/j.intimp.2020.106539
  • Shah N, Montes de Oca M, Jover-Cobos M, et al. Role of toll-like receptor 4 in mediating multiorgan dysfunction in mice with Acetaminophen induced acute liver failure. Liver Transplant. 2013;19(7):751–761. doi:10.1002/lt.23655
  • Lee J, Ha SJ, Lee HJ, et al. Protective effect of Tremella fuciformis Berk extract on LPS-induced acute inflammation via inhibition of the NF-κB and MAPK pathways. Food Funct. 2016;7(7):3263–3272. doi:10.1039/C6FO00540C
  • Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000;103(2):239–252. doi:10.1016/S0092-8674(00)00116-1
  • Yao H, Hu C, Yin L, et al. Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway. Int Immunopharmacol. 2016;36:132–141. doi:10.1016/j.intimp.2016.04.023
  • Al-Harbi NO, Imam F, Al-Harbi MM, et al. Dexamethasone attenuates LPS-induced acute lung injury through inhibition of NF-κB, COX-2, and pro-inflammatory mediators. Immunol Invest. 2016;45(4):349–369. doi:10.3109/08820139.2016.1157814
  • von Moltke J, Ayres JS, Kofoed EM, Chavarría-Smith J, Vance RE. Recognition of bacteria by inflammasomes. Annu Rev Immunol. 2013;31(1):73–106. doi:10.1146/annurev-immunol-032712-095944
  • Nicotera P, Leist M, Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett. 1998;102–103:139–142. doi:10.1016/S0378-4274(98)00298-7
  • Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114(4):842–845. doi:10.1016/S0016-5085(98)70599-2
  • Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol. 2015;62(3):720–733. doi:10.1016/j.jhep.2014.10.039
  • Mansouri RM, Baugé E, Staels B, Gervois P. Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-alpha control of the acute-phase response. Endocrinology. 2008;149(6):3215–3223. doi:10.1210/en.2007-1339
  • Stienstra R, Mandard S, Tan NS, et al. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver. J Hepatol. 2007;46(5):869–877. doi:10.1016/j.jhep.2006.11.019
  • Delerive P, Martin-Nizard F, Chinetti G, et al. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res. 1999;85(5):394–402. doi:10.1161/01.RES.85.5.394
  • Staels B, Koenig W, Habib A, et al. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature. 1998;393(6687):790–793. doi:10.1038/31701
  • Marx N, Sukhova GK, Collins T, Libby P, Plutzky J. PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation. 1999;99(24):3125–3131. doi:10.1161/01.CIR.99.24.3125
  • Van den Bossche J, O’Neill LA, Menon D. Macrophage immunometabolism: where are we (going)? Trends Immunol. 2017;38(6):395–406. doi:10.1016/j.it.2017.03.001
  • Hotamisligil GS. Foundations of immunometabolism and implications for metabolic health and disease. Immunity. 2017;47(3):406–420. doi:10.1016/j.immuni.2017.08.009
  • Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548–2556. doi:10.1210/jc.2004-0395
  • Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology. 2003;38(1):123–132. doi:10.1053/jhep.2003.50307
  • Stienstra R, Mandard S, Patsouris D, Maass C, Kersten S, Müller M. Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation. Endocrinology. 2007;148(6):2753–2763. doi:10.1210/en.2007-0014
  • Khovidhunkit W, Kim M-S, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45(7):1169–1196. doi:10.1194/jlr.R300019-JLR200
  • Feingold KR, Shigenaga JK, Kazemi MR, et al. Mechanisms of triglyceride accumulation in activated macrophages. J Leukoc Biol. 2012;92(4):829–839. doi:10.1189/jlb.1111537
  • Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496(7444):238–242. doi:10.1038/nature11986
  • Liu H, Han T, Tian J, et al. Monitoring oxidative stress in acute-on-chronic liver failure by advanced oxidation protein products. Hepatol Res. 2012;42(2):171–180. doi:10.1111/j.1872-034X.2011.00911.x
  • Doerrler W, Feingold KR, Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine. 1994;6(5):478–484. doi:10.1016/1043-4666(94)90074-4
  • IJlst L, Mandel H, Oostheim W, Ruiter JP, Gutman A, Wanders RJ. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency. J Clin Invest. 1998;102(3):527–531. doi:10.1172/JCI2927
  • Caputo T, Gilardi F, Desvergne B. From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions. FEBS Lett. 2017;591(19):3061–3088. doi:10.1002/1873-3468.12742
  • Kawasaki N, Asada R, Saito A, Kanemoto S, Imaizumi K. Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue. Sci Rep. 2012;2(1):799. doi:10.1038/srep00799
  • Wen J, Zou W, Wang R, et al. Cardioprotective effects of aconiti lateralis radix praeparata combined with zingiberis rhizoma on doxorubicin-induced chronic heart failure in rats and potential mechanisms. J Ethnopharmacol. 2019;238:111880. doi:10.1016/j.jep.2019.111880
  • Hou Y, Gu D, Peng J, et al. Ginsenoside Rg1 regulates liver lipid factor metabolism in NAFLD model rats. ACS Omega. 2020;5(19):10878–10890. doi:10.1021/acsomega.0c00529
  • Zhang Y, Ji H, Qiao O, et al. Nanoparticle conjugation of ginsenoside Rb3 inhibits myocardial fibrosis by regulating PPARα pathway. Biomed Pharmacother. 2021;139:111630. doi:10.1016/j.biopha.2021.111630
  • Li J, Wang S, Yao L, et al. 6-gingerol ameliorates age-related hepatic steatosis: association with regulating lipogenesis, fatty acid oxidation, oxidative stress and mitochondrial dysfunction. Toxicol Appl Pharmacol. 2019;362:125–135. doi:10.1016/j.taap.2018.11.001
  • Wang C, Duan X, Sun X, et al. Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice. Food Funct. 2016;7(9):3716–3723. doi:10.1039/C6FO00773B